Industry leaders argue that by permitting imports of refurbished devices, the policy undermines India’s self-reliance in medical manufacturing and negatively impacts domestic manufacturers
Read More
Speaking at the ‘MediTech Stackathon-II 2024,’ organised by FICCI in collaboration with the Department of Pharmaceuticals, Dr. Chawla emphasised the need for a post-PLI framework to support the industry and reduce import dependence
Read More
